1. Introduction {#sec1-jcm-09-01546}
===============

Type 2 diabetes (T2D) is a common disease associated with reduced life expectancy and considerable morbidity \[[@B1-jcm-09-01546]\]. Furthermore, T2D is commonly an asymptomatic condition \[[@B2-jcm-09-01546]\] associated with other non-communicable diseases, and causes a high number of hospitalizations and a significant economic impact \[[@B3-jcm-09-01546],[@B4-jcm-09-01546]\]. According to the International Diabetes Federation (Diabetes Atlas 2019), the prevalence of diabetes is increasing worldwide, and it is estimated to increase from 9.3% to 10.9% by 2045, affecting 700 million adults \[[@B5-jcm-09-01546]\]. In addition, about 50% of all people with diabetes worldwide are not diagnosed \[[@B1-jcm-09-01546]\]. Diabetes prevalence varies among regions, ranging from 5% to 20%, with a higher incidence in Oceania, the Caribbean, South Asia, the Middle East, Latin America, and Central Asia \[[@B6-jcm-09-01546]\].

Early detection of people with undiagnosed T2D is an important public health concern, as up to half of people with newly diagnosed T2D present one or more complications when it is diagnosed \[[@B7-jcm-09-01546],[@B8-jcm-09-01546]\]. Several large clinical trials have shown that diabetes could be prevented by recommending lifestyle changes such as advocating physical activity, a healthy low fat diet and weight reduction \[[@B3-jcm-09-01546],[@B9-jcm-09-01546],[@B10-jcm-09-01546]\]. These lifestyle changes have been shown to decrease the risk of diabetes by nearly 60% \[[@B9-jcm-09-01546],[@B11-jcm-09-01546],[@B12-jcm-09-01546],[@B13-jcm-09-01546],[@B14-jcm-09-01546]\]. Thus, policies focusing on diabetes prevention and early identification of T2D in populations at high risk may be worth seriously considering \[[@B15-jcm-09-01546]\]. Furthermore, some studies show how some diabetes risk scores, such as the German Diabetes Risk Score (GDRS) or the Atherosclerosis Risk in Communities model (ARIC 2009), allow the identification of high-risk target groups for cost-effective lifestyle interventions to prevent T2D \[[@B16-jcm-09-01546]\].

The worldwide number of published risk prediction tools for identifying individuals at risk of T2D has greatly increased in the last few years \[[@B15-jcm-09-01546],[@B17-jcm-09-01546],[@B18-jcm-09-01546]\]. However, there is no consensus on which is the best risk score and only a few of them end up being used in clinical practice. Prognostic risk-score models for T2D vary from those including only clinical variables to those with a genetic score and biochemical markers. These risk scores have been derived over a wide range of different populations.

T2D risk scores should be externally validated using data from different settings, populations, and ethnics groups, because generalization outside of the context in which they were designed could affect their performance and therefore, their external usefulness \[[@B18-jcm-09-01546]\]. A review and external validation of commonly used prediction tools including only clinical and conventional biomarkers demonstrated that risk prediction tools work properly in the validation cohorts \[[@B19-jcm-09-01546]\]. However, most of the models overestimate the number of people at high risk. These fitting differences could be explained by differences in population baseline characteristics and in the methodology used \[[@B20-jcm-09-01546],[@B21-jcm-09-01546],[@B22-jcm-09-01546],[@B23-jcm-09-01546]\]. Furthermore, ethnicity or diabetes incidence could play an important role in the differences between risk scores \[[@B24-jcm-09-01546]\].

The aims of this study were to systematically review predictive T2D equations and to analyze the agreement between these prediction risk scores in a cross-section study of Spanish Caucasian workers. Risk scores derived from populations with very different characteristics such as distinct ethnicities and a wide range of diabetes incidence were considered.

2. Material and Methods {#sec2-jcm-09-01546}
=======================

2.1. Search Strategy {#sec2dot1-jcm-09-01546}
--------------------

Articles that presented new risk prediction models for detecting T2D were identified. A systematic review was performed in Medline, PubMed, CINAHL, and EMBASE databases following PRISMA guidelines \[[@B25-jcm-09-01546]\] looking for articles that reported models or predictive equations for incident diagnosis of T2D until July 2018. The following search string was used: (("diabetes mellitus" OR "type 2 diabetes" OR "diabetes") AND ("predictive model" OR "predictive equation" OR "prediction model" OR "prediction rule" OR "risk assessment" OR "risk score") NOT ("review" OR "bibliography")). Articles were restricted to English, Portuguese, and Spanish language literature. Reference lists was also verified for relevant citations. The search strategy was performed in cooperation with a research librarian. Unpublished literature was identified through the Information System on Gray Literature in Europe (Open Gray), Conference Proceedings of the Web of Science and ProQuest Dissertations, and Theses Global.

References of the studies identified by the literature search strategy were imported into EndNote X9 (Clarivate Analytics, Philadelphia, PA, USA) literature management software, and duplicates were removed. One researcher (A.A.) screened for the titles and abstracts of all articles identified by the search string to exclude articles that did not report risk prediction models. After reviewing the retrieved titles, to ensure the quality of the process, two additional authors (J.A.A.-V. and M.B.-V.) independently reviewed the abstracts to select the relevant papers. Each article was randomly assigned to reviewers. Discrepancies between reviewers were solved by a third reviewer (A.L.). To reduce the risk of bias, a pilot exercise was carried out to apply the inclusion criteria in a sample of 10 references.

Study characteristics and study data was managed using Microsoft Excel 2013 (Microsoft Corp, Redmond, WA, USA, [www.microsoft.com](www.microsoft.com)) and Review Manager software (RevMan version 5.3, Copenhagen, Denmark: The Nordic Cochrane Centre, the Cochrane Collaboration 2014), respectively. A standardized form was used for data extraction, including general information (author(s), journal, location, year, country, and conflict of interest); population characteristics (age, sex, ethnicity, and inclusion and exclusion criteria); and study details (study design, sample size, statistical analysis, and bias). Articles where the model/equation included genetic testing or non-common biomarkers were excluded.

2.2. Study Design {#sec2dot2-jcm-09-01546}
-----------------

A cross-sectional study with Caucasian western European adult workers (aged 20--65 years) was performed. All subjects were from a Spanish Mediterranean area and belonged to different productive sectors (public administration, health department, and the post office). Study design, procedures and reporting followed guidance from the STROBE statement on observational studies \[[@B26-jcm-09-01546]\]. To evaluate the correlation of the retrieved prediction models, the original published prediction models were used (scores or original regression equations). Then, participants' risk of developing T2D was determined using the following models: diabetes and impaired glucose tolerance score (DETECT-2) \[[@B27-jcm-09-01546]\]; Danish Diabetes Risk Score (DDRS) \[[@B28-jcm-09-01546]\]; data from the epidemiological study on the insulin resistance syndrome score (DESIR) \[[@B29-jcm-09-01546]\]; Cambridge risk score \[[@B30-jcm-09-01546]\]; QDScore \[[@B31-jcm-09-01546]\]; FINDRISC score \[[@B32-jcm-09-01546]\]; EGAT score \[[@B33-jcm-09-01546]\]; Australian T2D risk score (AUSDRISC) \[[@B34-jcm-09-01546]\]; instrument for T2D score (ITD) \[[@B35-jcm-09-01546]\]; atherosclerosis risk in communities score (ARIC) \[[@B36-jcm-09-01546]\]; San Antonio prediction model risk score \[[@B37-jcm-09-01546]\]; Framingham offspring score \[[@B38-jcm-09-01546]\]; diabetes population risk tool score (DPoRT) \[[@B39-jcm-09-01546]\]; scores from Oman \[[@B40-jcm-09-01546]\], India (IDRS) \[[@B41-jcm-09-01546]\], Taiwan \[[@B42-jcm-09-01546]\], and Kyushu island of Japan \[[@B43-jcm-09-01546]\]; and scores from military officers of China \[[@B44-jcm-09-01546]\], and Mauritian Indians \[[@B45-jcm-09-01546]\]. Six predictive models selected in the systematic review were not included to analyze the correlation with the equation because it was impossible to calculate the score in the German Diabetes Risk Score (GDRS) \[[@B46-jcm-09-01546]\] and the modified GDRS \[[@B47-jcm-09-01546]\] because diet was not ascertained in our population. The Tromsø Study \[[@B48-jcm-09-01546]\], the Mauritan Indians risk score \[[@B45-jcm-09-01546]\], the Tehran lipid and glucose studies \[[@B49-jcm-09-01546]\], and the AusDiab \[[@B50-jcm-09-01546]\] general scores were not determined because the original paper did not report enough data to allow proper score calculations. Agreement between results was analyzed as it is indicated in the statistical analysis section.

2.3. Participants and Recruitment {#sec2dot3-jcm-09-01546}
---------------------------------

Participants in the study were recruited during their periodic health examination in the workplace between January 2008 and December 2010. Every day each worker was assigned a number, and half of the examined workers were randomly selected using a random number table. Thus, from a total population of 130,487 workers, 65,200 were invited to participate in the study. 14,946 (22.9%) refused to participate, leaving the final number of participants standing at 590,424 (77.1%), with 25,510 women (43.2%), and 33,532 men (56.8%). The mean age of the participants in the study was 39.7 years (SD 10.2). All participants were informed of the purpose of this study before they provided written informed consent to participate. Following the current legislation, members of the Health and Safety Committees were informed as well. The study protocol was in accordance with the Declaration of Helsinki and was approved by the Institutional Review Board of the Mallorca Health Management (GESMA). After acceptance, a self-reported complete medical history, including family and personal history, was recorded. The following inclusion criteria were considered: age between 18 and 65 years (working age population), being gainfully employed, and without a previous diagnosis of diabetes.

Subjects who did not meet any of the inclusion criteria and those who refused to participate were excluded from the study.

2.4. Samples and Measurements {#sec2dot4-jcm-09-01546}
-----------------------------

The methodology used was similar to the one previously reported \[[@B51-jcm-09-01546]\]. Anthropometric measurements were made in the morning at the same time, and according to the recommendations of the International Standards for Anthropometric Assessment (ISAK) \[[@B52-jcm-09-01546]\]. Furthermore, all measurements were performed by well-trained technicians or researchers to minimize coefficients of variation. Body weight (electronic scale Seca 700 scale, Seca GmbH, Hamburg, Germany), height (stadiometer Seca 220 CM Telescopic Height Rod for Column Scales, Seca GmbH, Hamburg, Germany), and abdominal waist circumference using a Lufkin Executive^®^ Thinline, precision 1 mm (Lufkin Executive Thinline, W606PM, Cooper Industries, Lexington, SC, USA) were determined according to the aforementioned recommended techniques. Body mass index (BMI) was calculated as weight (kg) divided by height (m) squared. Waist circumference was measured halfway between the lower costal border and the iliac crest. The measurement was made at the end of a normal expiration while the subject stood upright, with feet together and arms hanging freely at their sides.

Venous blood samples were taken after participants were seated at rest for at least 15 min from the antecubital vein with suitable vacutainers without anticoagulant to obtain serum. Blood samples were taken following a 12 h overnight fast. Concentrations of glucose, cholesterol and triglycerides were measured in serum by standard clinical biochemistry laboratory procedures using an automated hematology analyzer (SYNCHRON CX^®^9 PRO, Beckman Coulter, Brea, CA, USA).

2.5. Statistical Analysis {#sec2dot5-jcm-09-01546}
-------------------------

Descriptive analysis was used to report the frequency and distribution of categorical variables, whereas means and standard deviations (SDs) were reported for quantitative variables. The Spearman correlation coefficients were used to analyze the correlation between prediction scores of T2D. Participants were classified as high risk for developing diabetes if the cut-off points were reported in the publication; the following cut-off points were considered for classifying people at high risk: 31 points out of 60 in the Danish Diabetes Risk Score (DDRS); 7 points out of 32 in the Diabetes and Impaired Glucose Tolerance score (DETECT-2); 0.37 out of 1 point in the Cambridge score; a score of over 6 out of 20 in the FINDRISC; over 12 out of 43 in the Australian T2D Risk (AUSDRISK); over 60 out of 100 in the Indian Diabetes Risk Score (IDRS); over 6 out of 17 in the Electric Generating Authority of Thailand Study (EGATS); over 14 out of 49 in the Hisayama study; over 21 out of 40 in the National Urban Diabetes Survey (NUDS); and 55 out of 100 in the instrument for T2D (ITD). Agreement between 2 by 2 charts of participants classified as high risk was assessed using the kappa statistic. Statistical analyses were performed using IBM SPSS Statistics version 24 (SPSS/IBM, Chicago, IL, USA).

3. Results {#sec3-jcm-09-01546}
==========

The literature search strategy retrieved 820 original articles, 42 of which met the inclusion criteria considered ([Figure 1](#jcm-09-01546-f001){ref-type="fig"}).

The summarized characteristics of the studies included in the review are shown in [Table 1](#jcm-09-01546-t001){ref-type="table"}. We selected prediction tools developed from adult or middle adult populations that include predictors generally available in health records (demographics, history of parental diabetes or gestational diabetes, obesity, diet, lifestyle factors, obesity, antihypertensive medication, use of corticoids) as well as conventional biomarkers such as glucose, HDL-cholesterol, LDL-cholesterol, and triglycerides.

There were 26 papers from six continents, 9 prioritizing scores from Europe \[[@B28-jcm-09-01546],[@B29-jcm-09-01546],[@B30-jcm-09-01546],[@B31-jcm-09-01546],[@B32-jcm-09-01546],[@B46-jcm-09-01546],[@B47-jcm-09-01546],[@B48-jcm-09-01546],[@B53-jcm-09-01546]\], 9 from Asia \[[@B33-jcm-09-01546],[@B40-jcm-09-01546],[@B41-jcm-09-01546],[@B42-jcm-09-01546],[@B43-jcm-09-01546],[@B44-jcm-09-01546],[@B45-jcm-09-01546],[@B49-jcm-09-01546],[@B54-jcm-09-01546]\], 2 from Oceania \[[@B34-jcm-09-01546],[@B50-jcm-09-01546]\], 1 from South-America \[[@B35-jcm-09-01546]\], 5 from North-America \[[@B36-jcm-09-01546],[@B37-jcm-09-01546],[@B38-jcm-09-01546],[@B39-jcm-09-01546],[@B55-jcm-09-01546]\] and finally one including populations or participants from 3 continents (Africa, Asia, and Oceania) \[[@B27-jcm-09-01546]\].

[Table 2](#jcm-09-01546-t002){ref-type="table"} summarizes the characteristics of the excluded studies: those reporting the calibration of selected prediction tools \[[@B56-jcm-09-01546],[@B57-jcm-09-01546],[@B58-jcm-09-01546],[@B59-jcm-09-01546],[@B60-jcm-09-01546],[@B61-jcm-09-01546]\], performed in an elderly population \[[@B62-jcm-09-01546],[@B63-jcm-09-01546]\], only in men or hypertensive patients \[[@B64-jcm-09-01546],[@B65-jcm-09-01546]\], validation studies \[[@B66-jcm-09-01546],[@B67-jcm-09-01546]\], and those considering scores that include biomarkers or genotype determinations that are not easily available for clinicians \[[@B68-jcm-09-01546],[@B69-jcm-09-01546],[@B70-jcm-09-01546],[@B71-jcm-09-01546],[@B72-jcm-09-01546],[@B73-jcm-09-01546]\].

In the cross-sectional study, risk of developing T2D was determined in a large sample of workers (*n* = 59,042). Correlations between the retrieved prediction models were evaluated using the original published scores or original regression equations. Agreement between predictions risk scores was analyzed as well. [Table 3](#jcm-09-01546-t003){ref-type="table"} summarizes the characteristics of participants in the study.

[Table 4](#jcm-09-01546-t004){ref-type="table"} shows the Spearman correlation coefficients of the models. There is a wide range of correlation values, from low to high values of correlation. For example, correlations considering the Cambridge score range from 0.560 to 0.898, and correlations including the Framingham offspring range from 0.481 to 0.760. [Table 5](#jcm-09-01546-t005){ref-type="table"} shows the agreement (kappa) between risk predicted (high and non-high risk) and [Table S1 (Supplementary Material)](#app1-jcm-09-01546){ref-type="app"} shows the distribution of the population into high risk and non-high risk groups. Agreements found between the classifications using the different scores ranged from 0.412 (between the ARIC and the DESIR score) to 0.916 (between AUSDRISK and the Hisayama study).

4. Discussion {#sec4-jcm-09-01546}
=============

There is great variability between risk prediction models for developing T2D. These prediction models include a wide range of clinical variables and conventional biomarkers, from the most simple models including only age, waist circumference, parental history of diabetes, and physical exercise practice \[[@B41-jcm-09-01546]\], to the most complex including also dietary characteristics \[[@B16-jcm-09-01546],[@B46-jcm-09-01546],[@B47-jcm-09-01546]\], social deprivation measures \[[@B31-jcm-09-01546]\], educational level \[[@B48-jcm-09-01546]\], and ethnicity \[[@B31-jcm-09-01546],[@B34-jcm-09-01546],[@B37-jcm-09-01546],[@B39-jcm-09-01546]\].

The most commonly used risk predictors were age, BMI or obesity, family history of diabetes, and hypertension. There were differences in the weight of the risk predictors included in the equation, the adjusted odds ratio of obesity for undiagnosed T2D varied when comparing different countries from North Europe such as Denmark (≤30 kg/m^2^ vs. \<25 kg/m^2^) 4.4 (2.6--7.3) \[[@B28-jcm-09-01546]\] and Finland 2.99 (1.31--6.81) \[[@B32-jcm-09-01546]\] to those from Asia such as Thailand (≤27,5 kg/m^2^ vs. 23 kg/m^2^) 1.74 (1.17--2.60) \[[@B33-jcm-09-01546]\], and China (≤28 kg/m^2^ vs. 24 kg/m^2^) 1.56 (1.03--2.38) \[[@B44-jcm-09-01546]\]. As it can be observed, there were differences in the BMI cut-off point for obesity, which was lower in Asian populations. The prevalence of a risk factor such as obesity and the cut-off points also differed, ranging from 16.3% (≤30 kg/m^2^) in Demark \[[@B28-jcm-09-01546]\] to 6.3% (≤27.5 kg/m^2^) in the derivation cohort from the EGAT study in Thailand \[[@B33-jcm-09-01546]\].

In the present cross-sectional study, the scores of the retrieved prediction equations as well as the Spearman coefficients for the correlations between them were calculated. In the Caucasian population considered, no higher correlations were found between the scores derived from Caucasians and the ones derived from other ethnic groups, prevalence of diabetes, estimated cut-off points or country proximity. However, higher correlations were found between the scores that included only clinical variables than between those that included clinical and conventional biomarkers. Furthermore, higher correlations were found between models that included only hypertension as risk predictors of T2D than between those that included several cardiovascular risk factors (systolic and diastolic blood pressure, cholesterol, triglyceride levels, etc.) There is also poor agreement when models derived from "special populations" such as volunteers \[[@B29-jcm-09-01546]\], Chinese living in Taiwan \[[@B42-jcm-09-01546]\], or military officers \[[@B44-jcm-09-01546]\] were considered.

The percentage of people classified as high risk ranged from 3.1% \[[@B35-jcm-09-01546]\] to 47.1% \[[@B54-jcm-09-01546]\]. These differences could be due to the fact that the cut-off point to classify people at high risk of developing T2D is clearly related to the incidence of diabetes which, in the studies considered, ranged from 1.3% in an adult population in the UK \[[@B30-jcm-09-01546]\] to 26.6% in a Chinese population of military officers in Beijing \[[@B44-jcm-09-01546]\].

Our study suggests that when highly diverse diabetes incidence and ethnicity derived risk predictor models were applied in a Caucasian worker population, poor agreements were achieved. Furthermore, differences in people classified as at high risk were also observed. Agreement did not improve by prevalence of diabetes or country proximity. However, in a validation cohort in a worldwide population (Africa, Asia, Oceania, North America, and Europe) \[[@B20-jcm-09-01546]\], the area under the curve of white Caucasian population behaved similarly, and showed a better prediction between geographically closer countries, showing lower specificity when European developed risk prediction models were applied to African or Asian populations.

Agreement between models did not improve when ethnicity was considered in the models. In this regard, Tanamas \[[@B74-jcm-09-01546]\], in a multi-ethnic cohort validation of highly diverse ethnicity development predictive models, showed a modest influence of the ethnicity in the development cohort in the prediction but there was no evidence that models performed better in populations with a similarity between the development derivation ethnicity and the ethnics in the validation cohort. In this sense, Rosella \[[@B24-jcm-09-01546]\] in a multi-ethnic cohort showed that adding ethnicity did not improve discrimination or the accuracy of predictive models. The causes of the ethnic differences in T2D incidence are not well known. Specifically, the relative contributions of genetic and environmental factors to such differences are largely unknown. Only a few studies in isolated populations have shown evidence on how differences in frequencies of known T2D susceptibility genetic alleles account for ethnic differences \[[@B75-jcm-09-01546]\]. However, research for genetic susceptibility has not been uniform among the world's ethnic groups. Actually, ethnicity is associated with many other risk factors for T2D that may account for the race/ethnic differences in risk of T2D. These factors include, among others, obesity or overweight, prediabetes condition, diet characteristics, socioeconomic status, area of residence, and environmental contaminants \[[@B75-jcm-09-01546],[@B76-jcm-09-01546]\]. An improved understanding of the impact of these factors on T2D risk should lead to more effective preventive strategies. Performing better designed research must be a goal to understand the ethnic related risk for T2D. Belonging to similar ethnicities or showing similar T2D risk could not be the best way of ascertaining whether a model will perform properly in another population.

Although from the individual risk perspective, ethnicity information could be important, when predicting new cases of diabetes at the population level, detailed ethnic information has not been shown to improve discrimination and accuracy of the model or to identify a significant higher number of diabetics in the population. Therefore, it could be more important to develop models using measurements highly reproducible and available in the clinical practice.

Limitations
-----------

Our systematic review was limited to English, Portuguese, and Spanish language articles; therefore, we may have missed some useful studies. We would like to emphasize that the purpose of the study was to highlight the heterogeneity of the risk of developing diabetes in this population when using different risk prediction models. It was not possible to validate this onset of disease in participants in the present study since they were not followed up.

5. Conclusions {#sec5-jcm-09-01546}
==============

Numerous T2D prediction models exist based on readily available health data and provide an adequate but not perfect estimate of the chance of developing T2D in the future. The systematic review of 26 predictive models highlights a great heterogeneity in the risk predictors included and the cut-off points of some risk predictors. A poor reporting of the development procedure of the risk prediction models in terms of describing the data and providing sufficient detail in all steps taking in building the model has been observed. Furthermore, most of the models have not been externally validated. Ethnicity includes intrinsically important genetic and environmental factors related to diabetes onset; however, the evidence is still controversial as regards the influence of ethnicity as an independent risk predictor for T2D onset. Risk prediction models should be derived from the general population and further research is required to improve prediction of T2D.

Differences in diabetes incidence, prevalence, and weight of risk factors seem to account for the agreement differences between scores. In the Caucasian population of workers considered in the present study there is better agreement between the multi-ethnic derivate score (DETECT-2) and European derivate scores. Risk models development should change towards the use of more available and reproductible risk predictors.

The authors would like to thank all participants in the study and the colleagues who assisted in the data collection.

The following are available online at <https://www.mdpi.com/2077-0383/9/5/1546/s1>, Table S1: Distribution of people at high risk using DETECT-2, DDRS, FINDRISC, EGATS, NUDS, Hisayama, ITD and ARIC score.
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###### 

Models included for predicting risk of incident type 2 diabetes.

  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author/Year                                    Population           Risk Predictors                                 Name Risk Diabetes Score   Risk Predictors in the Model                                                                                                                                                                                                                                          Country                                                    \% Incidence Diabetes
  ---------------------------------------------- -------------------- ----------------------------------------------- -------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------- -----------------------
  Alssema 2011 \[[@B27-jcm-09-01546]\]           Adults               Clinical                                        DETECT-2                   Age, BMI, waist circumference, use of antihypertensive drugs and history of gestational diabetes                                                                                                                                                                      Europe, Australia and Africa                               4.6

  **Europe**                                                                                                                                                                                                                                                                                                                                                                                                                                                                      

  Glumer 2004 \[[@B28-jcm-09-01546]\]            Adults\              Clinical                                        DDRS                       Age, gender, body mass index, known hypertension, regular exercise, and family history of diabetes.                                                                                                                                                                   Three European countries (England, Netherlands, Denmark)   4.2
                                                 30--64 years                                                                                                                                                                                                                                                                                                                                                                                                                     

  Balkau 2008 \[[@B29-jcm-09-01546]\]            Adults volunteers\   Clinical                                        DESIR                      Men: Waist circumference, hypertension, smoking status\                                                                                                                                                                                                               western French                                             7.5
                                                 30--65 years                                                                                    Women: Waist circumference, family history of diabetes, hypertension                                                                                                                                                                                                                                                             

  Schulze 2007 \[[@B46-jcm-09-01546]\]           Adults\              Clinical and diet                               GDRS                       Age, waist circumference, height, history of hypertension, physical inactivity, smoking, consumption of red meat, whole grain bread, coffee, and alcohol                                                                                                              German (Epic-Potsdam)                                      3.4
                                                 35--65 years                                                                                                                                                                                                                                                                                                                                                                                                                     

  Muhlenbrunch 2014 \[[@B47-jcm-09-01546]\]      Adults\              Clinical and diet                               GDRS-modified              Age, waist circumference, height, history of hypertension, physical, inactivity, smoking, consumption of red meat, whole grain bread, coffee, alcohol and history of diabetes                                                                                         German (Epic-Potsdam)                                      2.2
                                                 35--65 years                                                                                                                                                                                                                                                                                                                                                                                                                     

  Simmons 2007 \[[@B53-jcm-09-01546]\]           Adults\              Clinical and diet                               EPIC-Norfolk               Age, gender, physical activity, family history of diabetes, BMI, smoking whole grain bread, fruits                                                                                                                                                                    UK (Epic-Norfolk)                                          1.7
                                                 40--79 years                                                                                                                                                                                                                                                                                                                                                                                                                     

  Rahman 2008 \[[@B30-jcm-09-01546]\]            Adults\              Clinical                                        Cambridge                  Age, gender, current use of corticosteroids, use of antihypertensive drugs, family history of diabetes, BMI, smoking                                                                                                                                                  UK-Norfolk Cohort                                          1.3
                                                 40--79 years                                                                                                                                                                                                                                                                                                                                                                                                                     

  Hippisley-Cox 2009 \[[@B31-jcm-09-01546]\]     Adults\              Clinical and an index of material deprivation   QDScore                    Age, gender, ethnicity, BMI, smoking, family history of diabetes, Townsend score, treated hypertension, cardiovascular disease, current use of corticosteroids                                                                                                        England (3--4% of another ethnicity)                       3.1
                                                 25--79 years                                                                                                                                                                                                                                                                                                                                                                                                                     

  Lindstrom 2013 \[[@B32-jcm-09-01546]\]         Adults\              Clinical                                        FINDRISC                   Age, BMI, waist circumference, use of antihypertensive drugs, history of hypertension                                                                                                                                                                                 Finland National Population Register                       4.1
                                                 35--64 years                                                                                                                                                                                                                                                                                                                                                                                                                     

  Joseph 2010 \[[@B48-jcm-09-01546]\]            Adults\              Clinical and biological                         The Tromsø Study           Age, BMI, total cholesterol, triglyceride level, high density lipoprotein cholesterol level, hypertension, family history of diabetes, education, physical inactivity, smoking                                                                                        North Norway                                               2.0
                                                 25--98 years                                                                                                                                                                                                                                                                                                                                                                                                                     

  **Asia**                                                                                                                                                                                                                                                                                                                                                                                                                                                                        

  Aekplakorn 2006 \[[@B33-jcm-09-01546]\]        Adult workers\       Clinical                                        EGATS                      Age, BMI, waist circumference, hypertension, family history of diabetes in first degree relative                                                                                                                                                                      Thailand                                                   11.1
                                                 35--55 years                                                                                                                                                                                                                                                                                                                                                                                                                     

  Al-Lawati 2007 \[[@B40-jcm-09-01546]\]         Adults\              Clinical                                        Omani                      Age, BMI, waist circumference, hypertension, family history of diabetes, current hypertension status                                                                                                                                                                  Oman                                                       prevalent cases
                                                 \>20 years                                                                                                                                                                                                                                                                                                                                                                                                                       

  Jahangiri 2013 \[[@B49-jcm-09-01546]\]         Adults\              Clinical and biological                         Teheran study              FPG, 2hPLG, TG, PAS, HDL-C and family history of diabetes                                                                                                                                                                                                             Iran                                                       10.1
                                                 \>20 years                                                                                                                                                                                                                                                                                                                                                                                                                       

  Mohan 2005 \[[@B41-jcm-09-01546]\]             Adults\              Clinical                                        IDRS                       Age, waist circumference, hypertension, family history of diabetes, current hypertension status                                                                                                                                                                       South Indian                                               15.5
                                                 \>18 years                                                                                                                                                                                                                                                                                                                                                                                                                       

  Ramachandran 2005 \[[@B54-jcm-09-01546]\]      Adults\              Clinical                                        NUDS                       Age, family history of diabetes, BMI, waist circumference, physical activity,                                                                                                                                                                                         Six cities national survey India                           4.6
                                                 \>20 year                                                                                                                                                                                                                                                                                                                                                                                                                        

  Gao 2009 \[[@B45-jcm-09-01546]\]               Adults\              Clinical                                        NS                         BMI, waist circumference, family history of diabetes                                                                                                                                                                                                                  Mauritians Indian                                          16.5
                                                 20--65 years                                                                                                                                                                                                                                                                                                                                                                                                                     

  Liu 2011 \[[@B44-jcm-09-01546]\]               Adults\              Clinical and biological                         MJLPD                      Age, hypertension, history of high blood glucose level, BMI, fasting plasma glucose level, triglyceride level, high density lipoprotein cholesterol level                                                                                                             Military officer in Beijing, China                         26.6
                                                 40--90 years                                                                                                                                                                                                                                                                                                                                                                                                                     

  Chuang 2011 \[[@B42-jcm-09-01546]\]            Adults\              Clinical                                        Chinese-DRS                Age, gender, education, alcohol, BMI, waist circumference                                                                                                                                                                                                             Taiwan                                                     6.5
                                                 \>35 years                                                                                                                                                                                                                                                                                                                                                                                                                       

  DoI 2012 \[[@B43-jcm-09-01546]\]               Adults\              Clinical                                        Hisayama study             Age, gender, family history of diabetes, abdominal circumference, body mass index, hypertension, regular exercise and current smoking                                                                                                                                 Japanese Kyushu island                                     14.7
                                                 40--79 years                                                                                                                                                                                                                                                                                                                                                                                                                     

  **Oceania**                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  Cameron 2008 \[[@B50-jcm-09-01546]\]           Adults\              Clinical and biological                         AusDiab                    Age, gender, ethnicity, fasting plasma glucose level, systolic blood pressure, high density lipoprotein cholesterol level, BMI, parental history of diabetes                                                                                                          Australian main Caucasian                                  3.8
                                                 \>25 years                                                                                                                                                                                                                                                                                                                                                                                                                       

  Chen 2010 \[[@B34-jcm-09-01546]\]              Adults\              Clinical                                        AUSDRISK                   Age, gender, BMI, ethnicity, physical inactivity, smoking, history of high blood pressure, use of antihypertensive medication, waist circumference, parental history of diabetes                                                                                      Australian main Caucasian                                  5.9
                                                 \>25 years                                                                                                                                                                                                                                                                                                                                                                                                                       

  **South-America**                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Guerrero-Romero 2010 \[[@B35-jcm-09-01546]\]   Adults               Clinical and biological                         ITD                        Age, gender, family history of diabetes, family history of hypertension, family history of obesity, history of gestational diabetes or macrosomia, fasting plasma glucose level, physical inactivity, triglyceride level, systolic or diastolic blood pressure, BMI   México                                                     14.1

  **North-America**                                                                                                                                                                                                                                                                                                                                                                                                                                                               

  Schmidt 2005 \[[@B36-jcm-09-01546]\]           Adults\              Clinical and biological                         ARIC                       Age, waist circumference, height, systolic blood pressure, family history of diabetes, ethnicity, fasting plasma glucose level, HDL, Triglycerides                                                                                                                    US                                                         16.3
                                                 45--64 years                                                                                                                                                                                                                                                                                                                                                                                                                     

  Stern 2002 \[[@B37-jcm-09-01546]\]             Adults\              Clinical and biologicals                        San Antonio                Age, gender, ethnicity, fasting plasma glucose level, systolic blood pressure, high density lipoprotein cholesterol level, BMI, family history of diabetes in first degree relative                                                                                   US (61% Mexican Americans)                                 9.2
                                                 25--64 years                                                                                                                                                                                                                                                                                                                                                                                                                     

  Wilson 2007 \[[@B38-jcm-09-01546]\]            Middle aged          Clinical and biological                         Framingham Offspring       Fasting plasma glucose level, BMI, high density lipoprotein cholesterol level, parental history of diabetes, triglyceride level, blood pressure                                                                                                                       US (Framingham)                                            5.1

  Kahn 2009 \[[@B55-jcm-09-01546]\]              Adults               Clinical and biological                         ARIC enhanced              Family history of diabetes (mother or father), hypertension, ethnicity, age, alcohol, waist circumference, height, resting pulse, glucose level, triglycerides, HDL cholesterol, uric acid                                                                            US                                                         19.0

  Rosella 2011 \[[@B39-jcm-09-01546]\]           Adults\              Clinical                                        DPoRT                      Age, ethnicity, BMI, hypertension, immigrant status, smoking, education, cardiovascular disease                                                                                                                                                                       Ontario Canada                                             7.1
                                                 \>20 years                                                                                                                                                                                                                                                                                                                                                                                                                       
  -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

DETECT-2: Diabetes and Impaired Glucose Tolerance; DDRS: Danish Diabetes Risk Score; DESIR: Data from the Epidemiological Study on the Insulin Resistance Syndrome; GDRS: German Diabetes Risk Score; EPIC-Norfolk: European Prospective Investigation of Cancer and Nutrition; Cambridge: Cambridge Risk Score; FINDRISC: Finnish Diabetes Risk Score; EGATS: Electric Generating Authority of Thailand Study; IDRS: The Indian Diabetes Risk Score; NUDS: National Urban Diabetes Survey; MJLPD: MJ Longitudinal health-check-up-based Population Database; Chinese-DRS: Chinese Diabetes Risk Score; AusDiab: Australian Diabetes, Obesity and Lifestyle study; AUSDRISK: Australian Type 2 Diabetes RISK; ITD: Instrument for type 2 diabetes (ITD); ARIC: Atherosclerosis Risk in Communities; San Antonio: San Antonio prediction model; Framingham offspring: Framingham Offspring Score; DPoRT: Diabetes Population Risk Tool.

jcm-09-01546-t002_Table 2

###### 

Models excluded for predicting risk of incident type 2 diabetes.

  Author/Year                                    Name Risk Diabetes                                                                                                 Risk Predictors in the Model                                                                                                                                                                                                                                       Reason for Exclusion
  ---------------------------------------------- ------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ --------------------------------------------------------
  Alssema 2008 \[[@B56-jcm-09-01546]\]           PREVEND (Modified FINDRISC for Dutch population)                                                                   Age, BMI, waist circumference, use of antihypertensive drugs, history of gestational diabetes                                                                                                                                                                      Calibration of FINDRISC
  Von Eckardstein 2000 \[[@B65-jcm-09-01546]\]   PROCAM score                                                                                                       Age, BMI, hypertension, glucose, family history of diabetes, high density lipoprotein cholesterol level                                                                                                                                                            Only men
  Bozorgmanesh 2013 \[[@B57-jcm-09-01546]\]      Modified ARIC-Teheran                                                                                              Family history of diabetes, systolic blood pressure, waist--height ratio, triglyceride-high density lipoprotein ratio, fasting plasma glucose level, two-hour postprandial plasma glucose level                                                                    Calibration of ARIC
  Chien 2009 \[[@B58-jcm-09-01546]\]             Cambridge Risk score -Taiwan                                                                                       Age, BMI, white blood cell count, triglyceride level, high density, lipoprotein cholesterol level, fasting plasma glucose level                                                                                                                                    Calibration of Cambridge score in Taiwanese population
  McNeely 2003 \[[@B66-jcm-09-01546]\]                                                                                                                              Age, sex, ethnicity, BMI, systolic blood pressure, fasting plasma glucose level, high density lipoprotein cholesterol level, family history of diabetes in first degree relative                                                                                   Validation study
  Wong 2013 \[[@B73-jcm-09-01546]\]                                                                                                                                 Sex, age, systolic blood pressure, waist, total cholesterol, HDL-C, triglycerides and HbA1c                                                                                                                                                                        Include complex biomarkers
  Gupta 2008 \[[@B64-jcm-09-01546]\]                                                                                                                                Fasting Plasma Glucose (FPG), history of diabetes and drug or dietary therapy for diabetes. Presence of both impaired FPG (\>6 and \<7 mmol/L) and glycosuria                                                                                                      Only hypertensive population
  Ku 2013 \[[@B60-jcm-09-01546]\]                Findrisk in a Philippine population                                                                                Age, BMI, waist circumference, use of antihypertensive drugs, history of hypertension                                                                                                                                                                              Calibration Find Risk
  Kanaya 2005 \[[@B63-jcm-09-01546]\]                                                                                                                               Age, sex, triglyceride level, fasting plasma glucose level                                                                                                                                                                                                         Old adults
  Kolberg 2009 \[[@B68-jcm-09-01546]\]           Inter99                                                                                                            Six biomarkers: adiponectin, C reactive protein, ferritin, glucose, interleukin 2 receptor A, insulin                                                                                                                                                              Include complex biomarkers
  Chin 2012 \[[@B59-jcm-09-01546]\]              The ARIC predictive model reliably predicted risk of type 2 diabetes in Asian populations                          Waist circumference, parental history of diabetes, hypertension, short stature, black race, age, weight, pulse, smoking                                                                                                                                            Calibration ARIC
  Guasch-Ferré 2012 \[[@B62-jcm-09-01546]\]      A risk score to predict type 2 diabetes mellitus in an elderly Spanish Mediterranean population                    BMI, smoking status, family history of type 2 diabetes, alcohol consumption and hypertension                                                                                                                                                                       Old adults
  Vassy 2012 \[[@B72-jcm-09-01546]\]             Genotype prediction of adult type 2 diabetes from adolescence in a multiracial population                          Demographics, family history, physical examination, routine biomarkers, and 38 single-nucleotide polymorphism diabetes genotype score                                                                                                                              Include a genotype score to predict diabetes
  Raynor 2013 \[[@B70-jcm-09-01546]\]            Novel risk factors and the prediction of type 2 diabetes in the Atherosclerosis Risk in Communities (ARIC) study   Adiponectin, leptin, γ-glutamyl transferase, ferritin, intercellular adhesion molecule 1, complement C3, white blood cell count, albumin, activated partial thromboplastin time, factor VIII, magnesium, hip circumference, heart rate, and a genetic risk score   Include genotype
  Sun 2009 \[[@B61-jcm-09-01546]\]               The ARIC predictive model reliably predicted risk of type 2 diabetes in Taiwanese population                       Waist circumference, parental history of diabetes, hypertension, short stature, black race, age, weight, pulse, smoking                                                                                                                                            Calibration of ARIC
  Meigs 2008 \[[@B69-jcm-09-01546]\]                                                                                                                                Age, sex, family history of diabetes, BMI, triglyceride level, fasting plasma glucose level, systolic blood pressure, high density lipoprotein cholesterol level and genotype score                                                                                Include genotype
  Nichols 2008 \[[@B67-jcm-09-01546]\]                                                                                                                              Age, sex, parental history of diabetes, BMI, hypertension or antihypertensive drugs, high density lipoprotein cholesterol level, triglyceride level, fasting plasma glucose level                                                                                  Validation of the Framingham Offspring Study equations
  Urdea 2009 \[[@B71-jcm-09-01546]\]             PreDx diabetes risk score                                                                                          Levels of adiponectin, C reactive protein, ferritin, glucose, hemoglobinA1c, interleukin 2, insulin                                                                                                                                                                Include complex biomarkers

jcm-09-01546-t003_Table 3

###### 

Baseline participants' characteristics (*n* = 59,042).

                                      Mean (SD)/*n* (%)
  ----------------------------------- -------------------
  Age (years)                         39.7 ± 10.2
  Men                                 33,532 (56.8)
  Smoking                             20,612 (34.9)
  Body Mass Index (kg/m^2^)           26.0 ± 4.6
  Waist circumference (cm)            82.7 ± 11.6
  Systolic blood pressure (mmHg)      120.3 ± 16.0
  Diastolic blood pressure (mmHg)     73.4 ± 10.9
  Cholesterol (mg/dL)                 194.7 ± 37.7
  High-density lipoproteins (mg/dL)   52.6 ± 8.5
  Low-density lipoproteins (mg/dL)    121.2 ± 37.1
  Triglycerides (mg/dL)               107.6 ± 73.0
  Fasting plasma glucose (mg/dL)      86.4 ± 12.0

jcm-09-01546-t004_Table 4

###### 

Correlation between models included for predicting risk of type 2 diabetes.

                         DETECT-2     DDRS         DESIR        Cambridge    QDScore      FINDRISC     EGATS        Omani Score   IDRS         NUDS         MJLPD        Chinese DRS   Hisayama Study   AUSDRISK     ITD          ARIC         San Antonio   Framingham Offspring   DPoRT        ARIC Enhanced
  ---------------------- ------------ ------------ ------------ ------------ ------------ ------------ ------------ ------------- ------------ ------------ ------------ ------------- ---------------- ------------ ------------ ------------ ------------- ---------------------- ------------ ---------------
  DETECT-2               1            0.754 \*\*   0.779 \*\*   0.842 \*\*   0.762 \*\*   0.793 \*\*   0.761 \*\*   0.680 \*\*    0.668 \*\*   0.710 \*\*   0.780 \*\*   0.574 \*\*    0.807 \*\*       0.862 \*\*   0.591 \*\*   0.500 \*\*   0.579 \*\*    0.585 \*\*             0.829 \*\*   0.616 \*\*
  DDRS                   0.754 \*\*   1            0.515 \*\*   0.881 \*\*   0.926 \*\*   0.872 \*\*   0.832 \*\*   0.881 \*\*    0.866 \*\*   0.911\*\*    0.851\*\*    0.659 \*\*    0.831 \*\*       0.777 \*\*   0.826 \*\*   0.595 \*\*   0.691 \*\*    0.691 \*\*             0.894 \*\*   0.609 \*\*
  DESIR                  0.779 \*\*   0.515 \*\*   1            0.634 \*\*   0.541 \*\*   0.611 \*\*   0.629 \*\*   0.519 \*\*    0.562 \*\*   0.522 \*\*   0.712 \*\*   0.535 \*\*    0.711 \*\*       0.775 \*\*   0.464 \*\*   0.412 \*\*   0.443 \*\*    0.481 \*\*             0.598 \*\*   0.519 \*\*
  Cambridge              0.842 \*\*   0.881 \*\*   0.634 \*\*   1            0.898 \*\*   0.777 \*\*   0.814 \*\*   0.754 \*\*    0.794 \*\*   0.823 \*\*   0.848 \*\*   0.639 \*\*    0.865 \*\*       0.838 \*\*   0.683 \*\*   0.560 \*\*   0.705 \*\*    0.644 \*\*             0.864 \*\*   0.560 \*\*
  QDScore                0.762 \*\*   0.926 \*\*   0.541 \*\*   0.898 \*\*   1            0.807 \*\*   0.854 \*\*   0.854 \*\*    0.820 \*\*   0.893 \*\*   0.846 \*\*   0.642 \*\*    0.793 \*\*       0.736 \*\*   0.767 \*\*   0.592 \*\*   0.694 \*\*    0.638 \*\*             0.853 \*\*   0.582 \*\*
  FINDRISC               0.793 \*\*   0.872 \*\*   0.611 \*\*   0.777 \*\*   0.807 \*\*   1            0.846 \*\*   0.755 \*\*    0.838 \*\*   0.837 \*\*   0.807 \*\*   0.687 \*\*    0.800 \*\*       0.813 \*\*   0.814 \*\*   0.604 \*\*   0.620 \*\*    0.748 \*\*             0.859 \*\*   0.749 \*\*
  EGAT study             0.761 \*\*   0.832 \*\*   0.629 \*\*   0.814 \*\*   0.854 \*\*   0.846 \*\*   1            0.733 \*\*    0.752 \*\*   0.809 \*\*   0.866 \*\*   0.669 \*\*    0.786 \*\*       0.801 \*\*   0.663 \*\*   0.534 \*\*   0.600 \*\*    0.634 \*\*             0.817 \*\*   0.609 \*\*
  Omani score            0.680 \*\*   0.881 \*\*   0.519 \*\*   0.754 \*\*   0.854 \*\*   0.755 \*\*   0.733 \*\*   1             0.730 \*\*   0.836 \*\*   0.743 \*\*   0.581 \*\*    0.715 \*\*       0.613 \*\*   0.804 \*\*   0.565 \*\*   0.604 \*\*    0.577 \*\*             0.747 \*\*   0.554 \*\*
  IDRS                   0.668 \*\*   0.866 \*\*   0.562 \*\*   0.794 \*\*   0.820 \*\*   0.838 \*\*   0.752 \*\*   0.730 \*\*    1            0.851 \*\*   0.806 \*\*   0.631 \*\*    0.830 \*\*       0.761 \*\*   0.784 \*\*   0.580 \*\*   0.651 \*\*    0.650 \*\*             0.787 \*\*   0.645 \*\*
  NUDS study             0.710 \*\*   0.911 \*\*   0.522 \*\*   0.823 \*\*   0.893 \*\*   0.837 \*\*   0.809 \*\*   0.836 \*\*    0.851 \*\*   1            0.797 \*\*   0.627 \*\*    0.787 \*\*       0.720 \*\*   0.755 \*\*   0.586 \*\*   0.641 \*\*    0.640 \*\*             0.813 \*\*   0.595 \*\*
  MJLPD study            0.780 \*\*   0.851 \*\*   0.712 \*\*   0.848 \*\*   0.846 \*\*   0.807 \*\*   0.866 \*\*   0.743 \*\*    0.806 \*\*   0.797 \*\*   1            0.695 \*\*    0.857 \*\*       0.887 \*\*   0.667 \*\*   0.551 \*\*   0.667 \*\*    0.644 \*\*             0.855 \*\*   0.594 \*\*
  Chinese DRS            0.574 \*\*   0.659 \*\*   0.535 \*\*   0.639 \*\*   0.642 \*\*   0.687 \*\*   0.669 \*\*   0.581 \*\*    0.631 \*\*   0.627 \*\*   0.695 \*\*   1             0.704 \*\*       0.680 \*\*   0.698 \*\*   0.610 \*\*   0.679 \*\*    0.788 \*\*             0.681 \*\*   0.650 \*\*
  Hisayama study         0.807 \*\*   0.831 \*\*   0.711 \*\*   0.865 \*\*   0.793 \*\*   0.800 \*\*   0.786 \*\*   0.715 \*\*    0.830 \*\*   0.787 \*\*   0.857 \*\*   0.704 \*\*    1                0.916 \*\*   0.686 \*\*   0.537 \*\*   0.663 \*\*    0.675 \*\*             0.811 \*\*   0.602 \*\*
  AUSDRISK               0.862 \*\*   0.777 \*\*   0.775 \*\*   0.838 \*\*   0.736 \*\*   0.813 \*\*   0.801 \*\*   0.613 \*\*    0.761 \*\*   0.720 \*\*   0.887 \*\*   0.680 \*\*    0.916 \*\*       1            0.590 \*\*   0.505 \*\*   0.631 \*\*    0.666 \*\*             0.846 \*\*   0.611 \*\*
  ITD                    0.591 \*\*   0.826 \*\*   0.464 \*\*   0.683 \*\*   0.767 \*\*   0.814 \*\*   0.663 \*\*   0.804 \*\*    0.784 \*\*   0.755 \*\*   0.667 \*\*   0.698 \*\*    0.686 \*\*       0.590 \*\*   1            0.619 \*\*   0.603 \*\*    0.760 \*\*             0.695 \*\*   0.695 \*\*
  ARIC                   0.500 \*\*   0.595 \*\*   0.412 \*\*   0.560 \*\*   0.592 \*\*   0.604 \*\*   0.534 \*\*   0.565 \*\*    0.580 \*\*   0.586 \*\*   0.551 \*\*   0.610 \*\*    0.537 \*\*       0.505 \*\*   0.619 \*\*   1            0.904 \*\*    0.623 \*\*             0.599 \*\*   0.632 \*\*
  San Antonio            0.579 \*\*   0.691 \*\*   0.443 \*\*   0.705 \*\*   0.694 \*\*   0.620 \*\*   0.600 \*\*   0.604 \*\*    0.651 \*\*   0.641 \*\*   0.667 \*\*   0.679 \*\*    0.663 \*\*       0.631 \*\*   0.603 \*\*   0.904 \*\*   1             0.673 \*\*             0.725 \*\*   0.706 \*\*
  Framingham offspring   0.585 \*\*   0.691 \*\*   0.481 \*\*   0.644 \*\*   0.638 \*\*   0.748 \*\*   0.634 \*\*   0.577 \*\*    0.650 \*\*   0.640 \*\*   0.644 \*\*   0.788 \*\*    0.675 \*\*       0.666 \*\*   0.760 \*\*   0.623 \*\*   0.673 \*\*    1                      0.676 \*\*   0.757 \*\*
  DPoRT                  0.829 \*\*   0.894 \*\*   0.598 \*\*   0.864 \*\*   0.853 \*\*   0.859 \*\*   0.817 \*\*   0.747 \*\*    0.787 \*\*   0.813 \*\*   0.855 \*\*   0.681 \*\*    0.811 \*\*       0.846 \*\*   0.695 \*\*   0.599 \*\*   0.725 \*\*    0.676 \*\*             1            0.644 \*\*
  ARIC enhanced          0.616 \*\*   0.609 \*\*   0.519 \*\*   0.560 \*\*   0.582 \*\*   0.749 \*\*   0.609 \*\*   0.554 \*\*    0.645 \*\*   0.595 \*\*   0.594 \*\*   0.650 \*\*    0.602 \*\*       0.611 \*\*   0.695 \*\*   0.632 \*\*   0.706 \*\*    0.757 \*\*             0.644 \*\*   1

\*\* *p* \< 0.001; DETECT-2: Diabetes and Impaired Glucose Tolerance; DDRS: Danish Diabetes Risk Score; DESIR: Data from the Epidemiological Study on the Insulin Resistance Syndrome; Cambridge: Cambridge Risk Score; QDScore: Qresearch Database Score; FINDRISC: Finnish Diabetes Risk Score risk; EGATS: Electric Generating Authority of Thailand Study; IDRS: The Indian Diabetes Risk Score; NUDS: National Urban Diabetes Survey; MJLPD: MJ Longitudinal health-check-up-based Population Database; Chinese-DRS: Chinese Diabetes Risk Score; AUSDRISK: Australian Type 2 Diabetes RISK; ITD: Instrument for type 2 diabetes; ARIC: Atherosclerosis Risk in Communities; San Antonio: San Antonio prediction model; Framingham offspring: Framingham Offspring Score; DPoRT: Diabetes Population Risk Tool.

jcm-09-01546-t005_Table 5

###### 

Agreement (kappa) between risk predicted (high and non-high risk) by DETECT-2, DDRS, FINDRISC, EGATS, and NUDS scores.

              DETECT-2   DDRS    Cambridge   FINDRISC   EGATS   NUDS    Hisayama   AUSDRISK   ITD     ARIC
  ----------- ---------- ------- ----------- ---------- ------- ------- ---------- ---------- ------- -------
  DETECT-2    NA         0.501   0.564       0.654      0.497   0.277   0.432      0.531      0.222   0.518
  DDRS        0.501      NA      0.638       0.518      0.473   0.293   0.327      0.395      0.271   0.298
  Cambridge   0.564      0.638   NA          0.555      0.633   0.414   0.541      0.524      0.187   0.293
  FINDRISC    0.654      0.518   0.555       NA         0.664   0.399   0.480      0.645      0.193   0.358
  EGATS       0.497      0.473   0.633       0.664      NA      0.562   0.624      0.713      0.121   0.249
  NUDS        0.277      0.293   0.414       0.399      0.562   NA      0.540      0.444      0.067   0.123
  Hisayama    0.432      0.327   0.541       0.480      0.624   0.540   NA         0.722      0.110   0.240
  AUSDRISK    0.531      0.395   0.524       0.645      0.713   0.444   0.722      NA         0.133   0.316
  ITD         0.222      0.271   0.187       0.193      0.121   0.067   0.110      0.133      NA      0.281
  ARIC        0.518      0.298   0.293       0.358      0.249   0.123   0.240      0.316      0.281   NA

DETECT-2: Diabetes and Impaired Glucose Tolerance; DDRS: Danish diabetes Risk score; Cambridge: Cambridge Risk Score; FIDRISC: Finnish Diabetes Risk Score risk; EGATS: Electric Generating Authority of Thailand Study; NUDS, National Urban Diabetes Survey; Hisayama: Hisayama study; AUSDRISK: Australian Type 2 Diabetes RISK; ITD: Instrument for type 2 diabetes; ARIC: Atherosclerosis Risk in Communities. NA: Non-Applicable.
